Aromatase inhibitors in advanced breast cancer: mechanism of action and clinical implications.
Brodie
A M
AM
Dept. Pharmacology and Experimental Therapeutics, School of Medicine, University of Maryland, Baltimore 21201, USA.
Njar
V C
VC
D000970:Antineoplastic Agents / Q000627:therapeutic use; D047072:Aromatase Inhibitors; D001943:Breast Neoplasms / Q000201:enzymology* / Q000628:therapy; D004791:Enzyme Inhibitors / Q000737:chemistry* / Q000627:therapeutic use; D004967:Estrogens / Q000502:physiology; D005260:Female; D006801:Humans; D015394:Molecular Structure; D013256:Steroids / Q000378:metabolism
D000970:Antineoplastic Agents; D047072:Aromatase Inhibitors; D004791:Enzyme Inhibitors; D004967:Estrogens; D013256:Steroids